We are live on ! Find out more
Focus Partners Wealth

Focus Partners Wealth Portfolio holdings

AUM $96.6B Turnover 19.32%
1-Year Est. Return 22.52%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+22.52%
3 Year Est. Return
+87.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$96.6B
AUM Growth
-$1.05B
Cap. Flow
-$1.82B
Cap. Flow %
-1.88%
Top 10 Hldgs %
22.3%
Holding
3,070
New
311
Increased
1,168
Reduced
1,215
Closed
282
Avg Time Held Equity + Options
1.5 years
Top 10 Avg Time Held Equity + Options
1.5 years
Top 20 Avg Time Held Equity + Options
1.6 years
Avg Time Held Equity only
1.5 years
Top 10 Avg Time Held Equity only
1.5 years
Top 20 Avg Time Held Equity only
1.6 years

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$246M
2
DHR icon
Danaher
DHR
+$159M
3
NVDA icon
NVIDIA
NVDA
+$143M
4
NFLX icon
Netflix
NFLX
+$131M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$120M

Sector Composition

Rank Sector Weight
1 Miscellaneous 52.06%
2 Technology 17.79%
3 Financials 7.2%
4 Communication Services 4.44%
5 Healthcare 4.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HAUZ icon
2326
Xtrackers International Real Estate ETF
HAUZ
$1.07B
$295K ﹤0.01%
13,902
+1,049
+8% +$23.7K
2025 Q4
3 quarters
TPC icon
2327
Tutor Perini Cor
TPC
$5.06B
$295K ﹤0.01%
3,576
+471
+15% +$40.5K
2025 Q4
3 quarters
EFAA icon
2328
Invesco MSCI EAFE Income Advantage ETF
EFAA
$667M
$295K ﹤0.01%
+5,370
New +$302K
2026 Q3
0 quarters
ASCE icon
2329
Allspring SMID Core ETF
ASCE
$169M
$295K ﹤0.01%
+9,006
New +$309K
2026 Q3
0 quarters
CRSP icon
2330
CRISPR Therapeutics
CRSP
$3.89B
$294K ﹤0.01%
5,317
-586
-10% -$31.6K
2025 Q2
5 quarters
HRMY icon
2331
Harmony Biosciences
HRMY
$1.94B
$294K ﹤0.01%
7,488
+640
+9% +$24.7K
2026 Q2
1 quarter
SCL icon
2332
Stepan
SCL
$1.5B
$293K ﹤0.01%
4,704
+238
+5% +$14.7K
2026 Q2
1 quarter
ICL icon
2333
ICL Group
ICL
$5.59B
$293K ﹤0.01%
58,426
+21,705
+59% +$116K
2025 Q4
3 quarters
CENTA icon
2334
Central Garden & Pet Class A
CENTA
$2.5B
$293K ﹤0.01%
8,748
-12
-0.1% -$445
2026 Q2
1 quarter
CNS icon
2335
Cohen & Steers
CNS
$3.51B
$293K ﹤0.01%
4,009
+58
+1% +$4.61K
2026 Q2
1 quarter
ENVA icon
2336
Enova International
ENVA
$4.15B
$293K ﹤0.01%
1,754
+40
+2% +$9.1K
2025 Q4
3 quarters
PBE icon
2337
Invesco Biotechnology & Genome ETF
PBE
$421M
$293K ﹤0.01%
+3,009
New +$282K
2026 Q3
0 quarters
CALF icon
2338
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.78B
$292K ﹤0.01%
5,485
-128
-2% -$7.03K
2025 Q2
5 quarters
LLYVK icon
2339
Liberty Live Group Series C
LLYVK
$9.7B
$292K ﹤0.01%
3,002
-490
-14% -$50.1K
2026 Q1
2 quarters
IBHG icon
2340
iShares iBonds 2027 Term High Yield and Income ETF
IBHG
$534M
$291K ﹤0.01%
13,378
– –
2025 Q4
3 quarters
IJAN icon
2341
Innovator International Developed Power Buffer ETF January
IJAN
$223M
$291K ﹤0.01%
7,575
-2,908
-28% -$112K
2024 Q2
9 quarters
GPIX icon
2342
Goldman Sachs S&P 500 Premium Income ETF
GPIX
$6.37B
$290K ﹤0.01%
5,200
+1,437
+38% +$80.1K
2026 Q2
1 quarter
AMX icon
2343
America Movil
AMX
$77B
$290K ﹤0.01%
13,664
-1,710
-11% -$41.2K
2026 Q1
2 quarters
ACVA icon
2344
DELISTED
ACV Auctions
ACVA
$289K ﹤0.01%
27,747
-292
-1% -$2.36K
2026 Q2
1 quarter
IBHF icon
2345
iShares iBonds 2026 Term High Yield and Income ETF
IBHF
$602M
$289K ﹤0.01%
12,832
– –
2025 Q1
6 quarters
FTHY icon
2346
First Trust High Yield Opportunities 2027 Term Fund
FTHY
$468M
$288K ﹤0.01%
22,420
-283
-1% -$3.78K
2025 Q4
3 quarters
KNSA icon
2347
Kiniksa Pharmaceuticals
KNSA
$7.47B
$287K ﹤0.01%
3,847
-371
-9% -$27.3K
2026 Q2
1 quarter
NAPR icon
2348
Innovator Growth-100 Power Buffer ETF April
NAPR
$201M
$287K ﹤0.01%
4,711
– –
2025 Q2
5 quarters
BIO.B icon
2349
Bio-Rad Laboratories Class B
BIO.B
$286K ﹤0.01%
+760
New +$244K
2026 Q3
0 quarters
ILCV icon
2350
PUT
iShares Morningstar Value ETF
ILCV
$1.37B
$286K ﹤0.01%
1,800
– –
2026 Q2
1 quarter

Similar funds

Focus Partners Wealth's Q3 2026 Portfolio in Review

As of Q3 2026, Focus Partners Wealth held 3,070 positions worth $96.6B, down 1.1% from $97.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Focus Partners Wealth's Q3 2026 filing shows 311 new, 1,168 increased, 1,215 reduced and 282 closed positions. Its largest new stake was Fairlead Tactical Sector ETF: 565,809 shares worth $17.7M. The largest sale was Dimensional US Core Equity 2 ETF, an estimated $1.83B.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 54% a quarter earlier, followed by Technology and Financials.

  • Focus Partners Wealth's largest Q3 2026 buy was Fairlead Tactical Sector ETF: 565,809 shares worth $17.7M.
  • Focus Partners Wealth added most to ExxonMobil in Q3 2026, an estimated $246M increase.
  • Focus Partners Wealth's biggest Q3 2026 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $1.83B.
  • Focus Partners Wealth fully exited Argan in Q3 2026, selling an estimated $8.3M.
  • Focus Partners Wealth's ten largest holdings make up 22% of its $96.6B portfolio in Q3 2026.
  • Focus Partners Wealth opened 311 new positions and closed 282 in Q3 2026.
  • Focus Partners Wealth's portfolio value fell 1.1% quarter-over-quarter to $96.6B.

Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.